Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis
β Scribed by N. Singh; Adriana Zeevi; Timothy Gayowski; Ignazio R. Marino
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 179 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis G virus (HGV) is a newly described RNA virus that is parenterally transmitted and has been found frequently in patients with chronic hepatitis C infection. To determine the impact of hepatitis G virus co-infection on morbidity and mortality following liver transplantation, we measured HGV
Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p
The clinical significance of HGV infection is uncertain. ## Although hepatitis G virus infection (HGV) is usually Hepatitis G viremia has been documented in patients with asymptomatic, it has been associated with mild hepatic injury. acute hepatitis 1,6,7 and can persist for years, 1,5-7 althoug
The association between the severity of chronic hepatitis C and the variability of the hepatitis C virus (HCV) genome remains controversial, but to our knowledge few data are available to date regarding T-cell epitope coding regions in transplant patients. In the current study, we identified 21 huma
Hepatitis C virus (HCV) has been proposed to have immunomodulatory effects in transplant recipients and may promote herpesvirus reactivation. To assess this, we compared the incidence of herpesvirus reactivation in HCV-positive and HCVnegative liver transplant recipients. Quantitative viral load tes